Terence M. Williams, MD, PhD, discussed the phase 1 DINOMITE trial of radiation therapy and papaverine in rectal cancer at ...

In arm 1 of the trial, the dose-escalation portion, patients will receive mRNA-4106 at a test dose as monotherapy. In arm 2, ...

“In our study in rectal cancer, preliminary data of dostarlimab ... they were to undergo standard-of-care neoadjuvant therapy for that tumor type, whether that was straight to surgery or ...

The extent of residual prostate cancer in the surgical specimen following intensified neoadjuvant therapy for high-risk localized prostate cancer may predict metastatic recurrence. Residual ...

A total neoadjuvant therapy (TNT) approach is strongly recommended for patients with T3 to T4 and node-positive rectal cancer ...

Key recommendations include the following: Neoadjuvant radiation therapy is recommended for patients with stage II or III rectal cancer to reduce their risk of locoregional recurrence. A thorough ...

guidelines for locally advanced rectal cancer treatment endorse watch-and-wait for patients with clinical complete response after neoadjuvant therapy,” said Zhao. “Our protocols follow established ...

There are 3 main ways that hormone therapy is used to treat patients with hormone-sensitive breast cancer: neoadjuvant therapy, adjuvant therapy, and treatment of patients with metastatic breast ...

Nisha Mohindra, MD, and Christopher Towe, MD, discuss what early-stage non-small cell lung cancer treatment options have looked like in the past and a more recent treatment option, neoadjuvant therapy ...

Study: Total neoadjuvant treatment using short ... The RAPIDO (short for Rectal Cancer and Preoperative Induction Therapy Followed by Dedicated Operation) trial compared CRT with a TNT regimen ...